The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...

As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

Dr. Albert Bourla is also troubled by this trend ... first for emergency use in December 2020 and then for full approval in August 2021. It’s also the vaccine that Israel has given to ...

The meeting, which will include Pfizer CEO Albert Bourla as the newly named board of directors’ chair, will reportedly cover ...

Albert Bourla, CEO of Pfizer since 2019 ... That move alone nearly doubled Pfizer’s revenues in fiscal year 2021 to around $81.3 billion. Since then, the company has fallen behind in the ...

Pfizer CEO Albert Bourla: $21,033,570 Albert Bourla started ... Ken Frazier is retiring in mid-2021. His final yearly pay package at Merck places him just inside the industry's top-ten highest ...

Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...

Pfizer's CEO Albert Bourla said that he's had dinner with Trump's health secretary pick, RFK Jr.Bourla said he was "cautiously optimistic" about the new administration.Kennedy is now close to securing ...

The pills are not yet approved by the Food and Drug Administration but could be before the end of 2021. Pfizer CEO Albert Bourla said the company is in talks with 90 countries about the drug.

Pfizer CEO Albert Bourla discusses the major mobilization to deliver a Covid-19 vaccine in record speed, and what it means for medical research, with WSJ's health and science coverage chief ...

CEO Albert Bourla says Pfizer has met the strategic goals it had set for itself in 2024, and that it was ‘executing transformative changes.’ ...

(Bloomberg) -- Pfizer Inc. and Albert Bourla got the upper hand in an early ... the drugmaker have fallen by more than 50% ...